Literature DB >> 19560117

Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.

Lena Silfverdal1, Levent Kemetli, Bengt Andrae, Pär Sparén, Walter Ryd, Joakim Dillner, Björn Strander, Sven Törnberg.   

Abstract

OBJECTIVE: We sought to evaluate the management of women with abnormal cytology in terms of subsequent risk of invasive cervical cancer. STUDY
DESIGN: The screening histories of all invasive cervical cancer cases diagnosed in Sweden 1999-2001 and of 5 population-based controls per case were reviewed. In all, 159 patients and 258 control subjects aged < 67 years had an abnormal smear result 0.5-6.5 years prior to cancer diagnosis. The cervical cancer risk was estimated in relation to management by calculating odds ratios.
RESULTS: Histologic assessment of low-grade squamous abnormalities strongly reduced the risk compared to repeated cytology (odds ratio, 0.46; 95% confidence interval, 0.24-0.89). Delaying histologic assessment was also associated with a higher risk (odds ratio, 5.65; 95% confidence interval, 1.39-23.05). After high-grade squamous atypia, absence of any cytologic or histologic specimen was a major determinant of cancer risk (odds ratio, 12.52; 95% confidence interval, 1.42-infinitive).
CONCLUSION: For adequate protection against invasive cervical cancer, further assessment with histology must be recommended also for women with low-grade squamous abnormalities.

Entities:  

Mesh:

Year:  2009        PMID: 19560117     DOI: 10.1016/j.ajog.2009.04.006

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Screening and cervical cancer cure: population based cohort study.

Authors:  Bengt Andrae; Therese M-L Andersson; Paul C Lambert; Levent Kemetli; Lena Silfverdal; Björn Strander; Walter Ryd; Joakim Dillner; Sven Törnberg; Pär Sparén
Journal:  BMJ       Date:  2012-03-01

2.  Cervical cancer screening in Sweden 2014-2016.

Authors:  Maria Hortlund; K Miriam Elfström; Pär Sparén; Pouran Almstedt; Björn Strander; Joakim Dillner
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

3.  Study of 2 years follow-up of referral patients with abnormal Pap smear.

Authors:  Fariba Behnamfar; Azam Zafarbakhsh; Taj-Alsadat Allameh
Journal:  J Res Med Sci       Date:  2015-12       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.